01
01

We are a group of experts from basic research and applied medical science, both from academia and industry, working together with the focus on the functionality of the albumin molecule in various diseases and related in vitro and clinical therapies, such as hemodialysis, albumin-dialysis in liver therapies and the use of this protein in apheresis-treatments.

02
02

Stefan Baudis

Vice President Global Affairs
CytoSorbents Europe

Albunet Finance

Gerd Klinkmann

Intensivist
University Hospital Rostock

Albunet President

Kristina Boss

Nephrologist
University Hospital Essen

Albunet Networking

03
03
04
04
105
05
  • BRIDGING THE KNOWLEDGE GAP BETWEEN SCIENTIFIC DISCOVERY AND CLINICAL APPLICATION: A CRUCIAL STEP FOR EFFECTIVE HEALTHCARE
    Gerd Klinkmann, Rostock, Germany
  • INDOXYL SULFATE CLEARANCE RISES WITH TEMPERATURE: BUT IS THERE A HYSTERESIS EFFECT?
    João Brás, Utrecht, the Netherlands
  • SELECTIVE REMOVAL OF GLYCATED AND OXIDIZED ALBUMIN BY ADSOPTION: MISSION IMPOSSIBLE?
    Jens Hartmann, Krems, Austria
  • ALTERATIONS OF ALBUMIN FUNCTION AFTER KIDNEY TRANSPLANTATION
    Kristna Boss, Essen, Germany
  • IMPACT OF HEMOADSORPTION ON LEVELS AND CHARACTERISTICS OF ALBUMIN – WHERE ARE WE?
    Maria Taborda-Kuepper, CytoSorbents Europe GmbH, Germany